229 related articles for article (PubMed ID: 23897762)
1. Generation and characterization of a tamoxifen-inducible Eomes(CreER) mouse line.
Pimeisl IM; Tanriver Y; Daza RA; Vauti F; Hevner RF; Arnold HH; Arnold SJ
Genesis; 2013 Oct; 51(10):725-33. PubMed ID: 23897762
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen-independent recombination in the RIP-CreER mouse.
Liu Y; Suckale J; Masjkur J; Magro MG; Steffen A; Anastassiadis K; Solimena M
PLoS One; 2010 Oct; 5(10):e13533. PubMed ID: 21063464
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the
Lesaffer B; Verboven E; Van Huffel L; Moya IM; van Grunsven LA; Leclercq IA; Lemaigre FP; Halder G
Cells; 2019 Apr; 8(4):. PubMed ID: 31027317
[TBL] [Abstract][Full Text] [Related]
4. Expression of tamoxifen-inducible CRE recombinase in Lcn5-CreER
Xu J; Yao G; Ru Y; Xie S
Mol Reprod Dev; 2017 Mar; 84(3):257-264. PubMed ID: 28029195
[TBL] [Abstract][Full Text] [Related]
5. A practical approach to genetic inducible fate mapping: a visual guide to mark and track cells in vivo.
Brown A; Brown S; Ellisor D; Hagan N; Normand E; Zervas M
J Vis Exp; 2009 Dec; (34):. PubMed ID: 20042997
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreER
Álvarez-Aznar A; Martínez-Corral I; Daubel N; Betsholtz C; Mäkinen T; Gaengel K
Transgenic Res; 2020 Feb; 29(1):53-68. PubMed ID: 31641921
[TBL] [Abstract][Full Text] [Related]
7. Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.
Boross P; Breukel C; van Loo PF; van der Kaa J; Claassens JW; Bujard H; Schönig K; Verbeek JS
Genesis; 2009 Nov; 47(11):729-35. PubMed ID: 19621440
[TBL] [Abstract][Full Text] [Related]
8. Inducible site-specific recombination in neural stem/progenitor cells.
Chen J; Kwon CH; Lin L; Li Y; Parada LF
Genesis; 2009 Feb; 47(2):122-31. PubMed ID: 19117051
[TBL] [Abstract][Full Text] [Related]
9. Generation of a mouse line harboring a Bi-transgene expressing luciferase and tamoxifen-activatable creER(T2) recombinase in cartilage.
Lo Cascio L; Liu K; Nakamura H; Chu G; Lim NH; Chanalaris A; Saklatvala J; Nagase H; Bou-Gharios G
Genesis; 2014 Feb; 52(2):110-9. PubMed ID: 24339176
[TBL] [Abstract][Full Text] [Related]
10. Generation of knock-in mice that express nuclear enhanced green fluorescent protein and tamoxifen-inducible Cre recombinase in the notochord from Foxa2 and T loci.
Imuta Y; Kiyonari H; Jang CW; Behringer RR; Sasaki H
Genesis; 2013 Mar; 51(3):210-8. PubMed ID: 23359409
[TBL] [Abstract][Full Text] [Related]
11. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
[TBL] [Abstract][Full Text] [Related]
12. Generation of a Tlx1(CreER-Venus) knock-in mouse strain for the study of spleen development.
Nakahara R; Kawai Y; Oda A; Nishimura M; Murakami A; Azuma T; Kaifu T; Goitsuka R
Genesis; 2014 Nov; 52(11):916-23. PubMed ID: 25283275
[TBL] [Abstract][Full Text] [Related]
13. Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase.
Chen M; Lichtler AC; Sheu TJ; Xie C; Zhang X; O'Keefe RJ; Chen D
Genesis; 2007 Jan; 45(1):44-50. PubMed ID: 17211877
[TBL] [Abstract][Full Text] [Related]
14. A dual-fluorescence reporter in the Eomes locus for live imaging and medium-term lineage tracing.
Probst S; Daza RA; Bader N; Hummel JF; Weiß M; Tanriver Y; Hevner RF; Arnold SJ
Genesis; 2017 Aug; 55(8):. PubMed ID: 28646547
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of a tamoxifen-inducible Vsx1-CreER
Baudouin C; Pelosi B; Courtoy GE; Achouri Y; Clotman F
Genesis; 2021 Aug; 59(7-8):e23435. PubMed ID: 34080769
[TBL] [Abstract][Full Text] [Related]
16. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
Undeutsch H; Löf C; Offermanns S; Kero J
Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of tamoxifen-inducible Pax9-CreER knock-in mice using CrispR/Cas9.
Feng J; Jing J; Sanchez-Lara PA; Bootwalla MS; Buckley J; Wu N; Yan Y; Chai Y
Genesis; 2016 Sep; 54(9):490-6. PubMed ID: 27381449
[TBL] [Abstract][Full Text] [Related]
18. Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.
Martinez-Corral I; Stanczuk L; Frye M; Ulvmar MH; Diéguez-Hurtado R; Olmeda D; Makinen T; Ortega S
Angiogenesis; 2016 Jul; 19(3):433-45. PubMed ID: 26993803
[TBL] [Abstract][Full Text] [Related]
19. Generation and analysis of a mouse line harboring GFP in the Eomes/Tbr2 locus.
Arnold SJ; Sugnaseelan J; Groszer M; Srinivas S; Robertson EJ
Genesis; 2009 Nov; 47(11):775-81. PubMed ID: 19830823
[TBL] [Abstract][Full Text] [Related]
20. High-fidelity
Ackermann AM; Zhang J; Heller A; Briker A; Kaestner KH
Mol Metab; 2017 Mar; 6(3):236-244. PubMed ID: 28271030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
